Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijid.2020.09.1450 http://scihub22266oqcxt.onion/10.1016/j.ijid.2020.09.1450 32992014!7521433!32992014     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Infect+Dis 2020 ; 101 (ä): 188-190 Nephropedia Template TP {{tp|p=32992014|t=2020. Favipiravir-induced fever in coronavirus disease 2019: A report of two cases |pdf=|usr=}}{{32992014}} gab.com Text Favipiravir-induced fever in coronavirus disease 2019: A report of two cases JO: Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32992014 #FOAvip Favipiravir, an antiviral agent, is undergoing clinical trials for treating novel coronavirus disease 2019 (COVID-19). Here, we report two cases of COVID-19 with favipiravir-induced fever. In both cases, pyrexia was observed following the administration of favipiravir despite improvements in symptoms of COVID-19. No other cause for fever was evident after careful physical examination and laboratory investigation. The fever subsided in both patients after the discontinuation of favipiravir. To the best of our knowledge, this is the first report of favipiravir-induced fever in COVID-19 patients. Twit Text FOAVip Favipiravir-induced fever in coronavirus disease 2019: A report of two cases ????Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32992014 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32992014 #FOAvip English Wikipedia <ref>{{Cite pmid|32992014}}</ref> Favipiravir-induced fever in coronavirus disease 2019: A report of two cases #MMPMID32992014 Takoi H; Togashi Y; Fujimori D; Kaizuka H; Otsuki S; Wada T; Takeuchi Y; Abe S Int J Infect Dis 2020[Dec]; 101 (ä): 188-190 PMID32992014show ga Favipiravir, an antiviral agent, is undergoing clinical trials for treating novel coronavirus disease 2019 (COVID-19). Here, we report two cases of COVID-19 with favipiravir-induced fever. In both cases, pyrexia was observed following the administration of favipiravir despite improvements in symptoms of COVID-19. No other cause for fever was evident after careful physical examination and laboratory investigation. The fever subsided in both patients after the discontinuation of favipiravir. To the best of our knowledge, this is the first report of favipiravir-induced fever in COVID-19 patients. |*COVID-19 Drug Treatment[MESH] |Adult[MESH] |Amides/administration & dosage/*adverse effects[MESH] |Antiviral Agents/administration & dosage/*adverse effects[MESH] |Body Temperature[MESH] |COVID-19/physiopathology[MESH] |Drug-Related Side Effects and Adverse Reactions/*etiology[MESH] |Female[MESH] |Fever/*etiology/physiopathology[MESH] |Humans[MESH] |Male[MESH] |Pyrazines/administration & dosage/*adverse effects[MESH] |SARS-CoV-2/drug effects/genetics/*physiology[MESH]Favipiravir-induced fever in coronavirus disease 2019: A report of two(epmc).pdf DeepDyve Pubget Overpricing